http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9992414
Outgoing Links
| Predicate | Object |
|---|---|
| contentType | Journal Article |
| endingPage | 137 |
| issn | 0976-5018 0976-500X |
| issueIdentifier | 2 |
| pageRange | 135-137 |
| publicationName | Journal of Pharmacology and Pharmacotherapeutics |
| startingPage | 135 |
| bibliographicCitation | S. E. D, S. M. Telavancin: A novel lipoglycopeptide antibiotic. Journal of Pharmacology and Pharmacotherapeutics. 2011 Jun;2(2):135–7. doi: 10.4103/0976-500x.81918. |
| creator | http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_459d712b59a6e7142a5d6333bded35e0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_057ce4a4998038913657635beefa28df |
| date | 201106 |
| identifier | https://pubmed.ncbi.nlm.nih.gov/PMC3127350 https://doi.org/10.4103/0976-500x.81918 https://pubmed.ncbi.nlm.nih.gov/21772784 |
| isPartOf | https://portal.issn.org/resource/ISSN/0976-500X https://portal.issn.org/resource/ISSN/0976-5018 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/38735 |
| language | English |
| source | https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/ |
| title | Telavancin: A novel lipoglycopeptide antibiotic |
Incoming Links
Total number of triples: 29.